UPenn's DM-Renal-Electrolyte Hypertens

Do you have or someone you know have Uncontrolled High Blood Pressure

The Hospital of the University of Pennsylvania
is participating in two new global clinical trials investigating the effect of renal denervation with the Investigational Simplicity Spyral™ catheter and Simplicity G3™ radiofrequency (RF) generator. Renal denervation is a minimally invasive, catheter-based procedure that may potentially calm the activity of nerves within the arteries leading to the kidneys. These nerves are part of the sympathetic nervous system, which helps the body control blood pressure. In people with hypertension, the renal nerves are hyperactive, raising blood pressure and contributing to heart, kidney and blood vessel damage. The two separate trials being conducted at the Hospital of the University of Pennsylvania are investigating the effect of renal denervation on high blood pressure in patients who are and who are not currently taking medications to lower their blood pressure.

“Uncontrolled high blood pressure is one of the greatest threats to patients living in Philadelphia,” said Debbie Cohen, M.D. in a recent Press Release and “We are proud to have been selected to take part in these groundbreaking trials, and look forward to helping identify which patients might be the most appropriate for this investigational treatment.”

Caution: The Symplicity™ Spyral™ catheter and Symplicity G3TM Generator are investigational devices and are limited by Federal Law to investigational use.